STAT3 and breast carcinoma: CDDO-Im has been shown to be a potent inhibitor of the epidermal growth factor receptor (EGFR) and STAT3/SRY-Box transcription factor 2 (Sox-2) signaling pathways in tumor-inducing macrophage (TIM) cells, which stimulate breast cancer growth and metastasis [112].